Fiche publication
Date publication
février 2022
Journal
Annales pharmaceutiques francaises
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FAGNONI Philippe
Tous les auteurs :
Le Du N, Arbaut JC, Dupont H, Berthou J, Fagnoni P
Lien Pubmed
Résumé
Health economic regulation and relevance of care are key points for every industrialised country. To get a better medicalised control of expenditure developments, French hospitals contracts with regulation authorities (Agence Régionale de Santé) and healthcare insurance within a "contract for the improvement of the quality and efficiency of care" (CAQES) One of the monitored element is fhe expenses related to hospital initial prescriptions delivered in community pharmacies (PHEV). The PHEV evolution isdriven by prescribing practices (in terms of relevance) But others explanatory factor are structural and more complex to identify.. Among these, the characteristics of the health care institution have a strong but unmeasured impact (environment, ambulatory medical demography, etc.). To evaluate the impact of these factors and help healthcare institutions, OMéDIT BFC (Regional Healthcare Products Observatory) and ARS, developed a tool for territorial management and analysis of PHEV named OPTA-PHEV. It makes it possible to individualize their expenditure data and to identify any prescription atypicalities integrating these extrinsic parameters. This will make it possible to compare and put into perspective the different regions in order to optimize PHEV-related expenses.
Mots clés
Analyse personnalisée, CAQES, Health territory, Masterized medical expenses, Maîtrise médicalisée, OPTA-PHEV, Personalized analysis, Territoire de santé
Référence
Ann Pharm Fr. 2022 Feb 10;:
